The data center construction market is experiencing significant innovations and features. These include modular designs, prefabricated components, and energy-efficient solutions that reduce construction time and operational costs. Additionally, data centers incorporate advanced cooling techniques, such as liquid cooling and hot/cold aisle containment, to enhance energy efficiency. Innovative security measures, such as biometric access controls and AI-driven surveillance, bolster data center protection. Moreover, scalable designs and cloud integration support the dynamic needs of modern businesses, making data centers adaptable and cost-effective in meeting evolving digital requirements.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-pharmaceutical-excipients-market
Data Bridge Market Research analyses that the North America Pharmaceutical Excipients Market value, which was USD 4,134.59 million in 2022, is expected to reach the value of USD 6,894.31 million by 2030, at a CAGR of 6.6% during the forecast period 2023-2030. The escalating incidence of chronic diseases is a significant driver in the pharmaceutical excipients market. To meet healthcare demands, a variety of excipients is essential for formulating medications that are both effective in treating chronic conditions and patient-friendly in terms of administration and compliance.
Key Findings of the Study
The global aging population is expected to drive the market's growth rate
The aging global population is a pivotal driver in the pharmaceutical excipients market. As the demographic shifts towards an older age bracket, there is an increasing demand for excipients tailored to the specific healthcare needs of elderly patients. Excipients play a crucial role in formulating medications that are effective and address the unique challenges associated with aging, ensuring optimal therapeutic outcomes for this expanding demographic.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Functionality (Binders and Adhesives, Disintegrants, Coating Material, Disintegrants, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America.
|
|
Market Players Covered
|
Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany), Dow (U.S.), Croda International Plc (U.K.), Roquette Frères (France), The Lubrizol Corporation (U.S.), BASF SE (Germany), Avantor, Inc. (U.S.), BENEO (Germany)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The North America pharmaceutical excipients market is segmented into functionality, dosage forms, route of administration, end user, and distribution channel.
- On the basis of functionality, the North America pharmaceutical excipients market is segmented into binders and adhesives, disintegrants, coating material, coloring agents, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidents, chelating agents, antifoaming agents, and others
- On the basis of dosage forms, the North America pharmaceutical excipients market is segmented into solid, semi-solid, and liquid
- On the basis of the route of administration, the North America pharmaceutical excipients market is segmented into oral pharmaceutical excipients, topical pharmaceutical excipients, parenteral pharmaceutical excipients, and other pharmaceutical excipients
- On the basis of end user, the North America pharmaceutical excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organizations, academics, and others
- On the basis of distribution channel, the North America pharmaceutical excipients market is segmented into direct tender, retail sales, and others
Major Players
Data Bridge Market Research recognizes the following companies as the North America pharmaceutical excipients market players in North America pharmaceutical excipients market are Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany).
Market Developments
- In October 2023, Clariant, a sustainability-driven specialty chemicals company, launched a robust portfolio of pharmaceutical ingredient solutions. Aligned with their commitment to sustainability, Clariant Health Care expanded its functional excipients range, addressing challenges in active pharmaceutical ingredient (API) delivery and bioavailability. These innovations contribute to the development of safer and more effective medicines
- In September 2023, Roquette, a prominent player in plant-based ingredients and pharmaceutical excipients, launched three new excipient grades. These additions to their portfolio specifically cater to moisture-sensitive active pharmaceutical and nutraceutical ingredients. Roquette continues to enhance its offerings, providing solutions that maintain the stability and efficacy of sensitive ingredients in pharmaceutical and nutraceutical formulations
- In February 2022, Kerry Group Plc. elevated its biotechnology standing through two strategic acquisitions. The company acquired c-LEcta, a pioneering biotech firm focused on precision fermentation, bio-processing, and bio-transformation. Additionally, the acquisition of Enmex, a respected enzyme manufacturer in Mexico, fortified Kerry's bio-process solutions for diverse markets, contributing to enhanced expertise, expanded technology offerings, and increased revenue
- In September 2022, DFE Pharma, a prominent North American provider of pharma- and nutraceutical excipients, inaugurated its "Closer to the Formulator" (C2F) Center of Excellence in Hyderabad, India. This facility accelerates pharmaceutical development, aiding companies in reducing the timeline from concept to finished commercial products. C2F serves as a testament to DFE Pharma's advancements in the field
- In 2020, Colorcon launched the Acryl-EZE II film coating line, expanding the pH range covered by its enteric coatings. This innovation enhances the versatility of enteric coatings, enabling pharmaceutical manufacturers to protect drugs from stomach acid and facilitate targeted release in the intestinal tract, contributing to improved efficacy and patient outcomes
Regional Analysis
Geographically, the countries covered in the North America pharmaceutical excipients market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is expected to dominate the North America pharmaceutical excipients market in the forecast period 2023-2030
The U.S. is expected to dominate North America pharmaceutical excipients market driven by advancements in healthcare IT. Integrating sophisticated technologies in healthcare enhances efficiency, data management, and drug development processes. This, in turn, fuels the demand for pharmaceutical excipients vital in drug formulation. The U.S. emerges as a key contributor to the market's expansion, exemplifying the intersection of healthcare and technology to drive innovation in the pharmaceutical industry across North America.
For more detailed information about the North America pharmaceutical excipients market report, click here – https://www.databridgemarketresearch.com/reports/north-america-pharmaceutical-excipients-market
